Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.
about
Review of the Reporting of Survival Analyses within Randomised Controlled Trials and the Implications for Meta-Analysis.A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.Radiotherapy and Hormone Treatment in Prostate CancerThe use of Hormonal Therapy to Augment Radiation Therapy in Prostate Cancer: An Update.Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation.The role of androgen deprivation therapy plus radiation therapy in patients with non-metastatic prostate cancer.Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202.Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer.Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial.Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition).Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome.A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients.Adjuvant androgen deprivation therapy for prostate cancer treated with radiation therapy
P2860
Q36009462-5770241D-2661-45FC-BD93-45C98DBF265FQ36480632-A0562590-1A85-452F-BB7F-D34FE0A8310DQ37176612-FA997AA7-D755-4848-AB16-E4E9F74966BBQ38673916-8631CE7E-A125-40CC-A623-7840EC8B8EF6Q38830640-A0506B57-9B75-46C5-A1A0-DE5AE571DA7EQ38910225-DD25D0B1-6A06-474D-8C97-ACB5D399B2EBQ38996911-4D2CF7F2-6D9E-488E-9E54-0A43C4B9FD42Q40400351-DFA0E47F-FEDB-4F6E-B71D-2E76E2359C73Q49871665-D4BEA4C4-520C-414A-9783-B66E90915029Q53734447-6D61FBBD-4E53-4CDB-A574-5C491F37412BQ55102922-91F8EDFC-D9BF-4A1C-B760-A0EE32F06D63Q55252859-8265FF13-951A-4610-B9FF-A87069D6729AQ57112442-94A605A2-0211-4C47-91CC-55E9C218583B
P2860
Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Duration of androgen suppressi ...... andomized clinical trial 9910.
@ast
Duration of androgen suppressi ...... andomized clinical trial 9910.
@en
Duration of androgen suppressi ...... andomized clinical trial 9910.
@nl
type
label
Duration of androgen suppressi ...... andomized clinical trial 9910.
@ast
Duration of androgen suppressi ...... andomized clinical trial 9910.
@en
Duration of androgen suppressi ...... andomized clinical trial 9910.
@nl
prefLabel
Duration of androgen suppressi ...... andomized clinical trial 9910.
@ast
Duration of androgen suppressi ...... andomized clinical trial 9910.
@en
Duration of androgen suppressi ...... andomized clinical trial 9910.
@nl
P2093
P2860
P356
P1476
Duration of androgen suppressi ...... andomized clinical trial 9910.
@en
P2093
Alexander G Balogh
Daniel Hunt
Daniel M Chinn
Elizabeth M Gore
Himanshu R Lukka
Howard M Sandler
James J Dignam
Leonard G Gomella
Mahul B Amin
Marie Duclos
P2860
P304
P356
10.1200/JCO.2014.58.0662
P407
P50
P577
2014-12-22T00:00:00Z